Patent Term Extended Under 35 U.S.C. 156(e)(2) An interim extension of the term of U.S. Patent No. 4,087,544 has been granted under 35 U.S.C. 156(e)(2) for a period of one year from the original expiration date of the patent. An application for patent term extension was filed by the patent owner of record Warner-Lambert Company based on approval of the product "NEURONTIN" by the Food and Drug Administration. Patent Term Extended Under 35 U.S.C. 156(e)(2) An interim extension of the term of U.S. Patent No. 4,219,478 has been granted under 35 U.S.C. 156(e)(2) for a period of one year from the original expiration date of the patent. An application for patent term extension was filed by the patent owner of record Farmitalia Carlo Erba S.r.l. based on approval of the product "MYCOBUTIN" by the Food and Drug Administration.